Skip to main content
logo
Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
477.10
-4.60 (-0.95%)
At close: Jul 31, 2026, 4:00 PM EDT
476.99
-0.11 (-0.02%)
After-hours: Jul 31, 2026, 7:59 PM EDT

Vertex Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
121,091115,149103,454104,85474,22055,884
Market Cap Growth
0.51%11.30%-1.33%41.27%32.81%-9.02%
Enterprise Value
110,080110,38898,88294,36364,25449,246
Last Close Price
477.10453.36402.70406.89288.78219.60

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
28.3029.59-29.2922.5324.37
Forward PE
25.0822.6122.6624.4418.8316.42
PEG Ratio
2.100.151.211.920.581.62
PS Ratio
9.919.599.3910.628.317.38
PB Ratio
6.266.176.305.965.335.53
P/TBV Ratio
6.876.827.176.776.126.56
P/FCF Ratio
32.6436.05-31.4218.9123.20
P/OCF Ratio
28.5631.71-29.6417.9721.14

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
9.019.208.979.567.196.50
EV/EBITDA Ratio
22.4725.18-23.5114.4216.94
EV/EBIT Ratio
23.5126.45-24.6214.9217.70
EV/FCF Ratio
29.6734.56-28.2816.3720.45

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.100.100.090.040.060.09
Debt / EBITDA Ratio
0.410.42-0.180.180.31
Debt / FCF Ratio
0.540.58-0.220.210.37
Net Debt / Equity Ratio
-0.27-0.25-0.28-0.60-0.72-0.66
Net Debt / EBITDA Ratio
-1.07-1.09177.88-2.61-2.24-2.28
Net Debt / FCF Ratio
-1.42-1.495.79-3.14-2.54-2.76
Asset Turnover
0.470.500.490.480.570.60
Inventory Turnover
0.971.141.572.102.662.85
Quick Ratio
2.382.242.173.604.464.04
Current Ratio
3.022.902.693.994.834.46
Return on Equity (ROE)
22.82%22.54%-3.15%22.99%27.67%24.93%
Return on Assets (ROA)
15.08%14.75%2.22%15.49%21.41%18.95%
Return on Invested Capital (ROIC)
28.08%27.61%5.30%57.42%91.29%74.81%
Return on Capital Employed (ROCE)
21.09%20.48%-1.22%22.16%32.27%26.29%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
3.58%3.38%-3.41%4.44%4.10%
FCF Yield
3.06%2.77%-3.18%5.29%4.31%
Buyback Yield / Dilution
0.15%-0.04%1.00%-0.54%0.31%1.33%
Total Shareholder Return
0.15%-0.04%1.00%-0.54%0.31%1.33%
SEC Filings: 10-K · 10-Q